Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

$217.4B

Market Cap • 4/3/2025

1996

(29 years)

Founded

1996

(29 years ago)

IPO

NYSE

Listing Exchange

Flag of CH

Basel

Headquarters